You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,744,277


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,744,277
Title:Aerosol delivery device and method of operating the aerosol delivery device
Abstract: An aerosol delivery device includes an aerosol generator for generating an aerosol in the aerosol delivery device with a membrane and a vibrator which is configured to vibrate a fluid and to aerosolise the fluid by the membrane. The aerosol delivery device further includes a fluid reservoir for receiving the fluid to be aerosolised, the fluid reservoir being arranged in fluid communication with the membrane, a controller which is configured to sequentially operate the vibrator at a plurality of different vibration frequencies, a sensor which is configured to detect at least one electrical parameter of the vibrator for each of the plurality of different vibration frequencies, and a detector which is configured to detect the presence of fluid in contact with the membrane and/or in the fluid reservoir on the basis of the dependence of the detected values of the at least one electrical parameter on the vibration frequency.
Inventor(s): Finke; Matthias (Munich, DE), Mutschmann; Dominique (Munich, DE), Achtzehner; Wolfgang (Alling, DE), Holzmann; Philipp (Munich, DE)
Assignee: PARI Pharma GmbH (Starnberg, DE)
Application Number:15/104,109
Patent Claim Types:
see list of patent claims
Use; Delivery; Device;
Patent landscape, scope, and claims:

United States Patent 10,744,277: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

The United States Patent 10,744,277, titled "Aerosol delivery device and method of operating the aerosol delivery device," is a significant patent in the field of medical devices and aerosol delivery systems. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Publication and Status

The patent, US10744277B2, was published on August 18, 2020, and is currently active, with an expiration date that can be determined based on the patent's filing and grant dates[4].

Inventors and Assignees

The patent was assigned to a specific entity, though the exact assignee is not specified in the provided sources. Understanding the assignee is crucial for determining the commercial and strategic implications of the patent.

Scope of the Patent

Technical Description

The patent describes an aerosol delivery device that includes an aerosol generator, a membrane, and a vibrator. The device is designed to generate an aerosol within the delivery device, which can be used for various medical applications, such as delivering drugs or other therapeutic substances[4].

Key Components

  • Aerosol Generator: This component is responsible for producing the aerosol.
  • Membrane: The membrane plays a critical role in the aerosol generation process.
  • Vibrator: The vibrator is used to enhance the aerosol generation and delivery.

Claims Analysis

Independent and Dependent Claims

The patent includes both independent and dependent claims. Independent claims define the broad scope of the invention, while dependent claims narrow down the scope by adding specific limitations.

  • Independent Claims: These claims outline the core elements of the aerosol delivery device, including the aerosol generator, membrane, and vibrator.
  • Dependent Claims: These claims specify additional features or modifications to the core elements, such as the material of the membrane or the frequency of the vibrator[4].

Claim Construction and Interpretation

Claim construction is a critical aspect of patent law, as it determines the scope of protection afforded to the patentee. The Federal Circuit has emphasized that claim construction is a question of law, subject to de novo review on appeal[2].

Patent Landscape

Prior Art and Anticipation

The patent landscape includes a review of prior art to ensure that the invention is novel and non-obvious. The USPTO and other patent offices worldwide conduct thorough searches to identify relevant prior art. In the case of US10744277B2, the prior art keywords include terms like "fluid," "membrane," "delivery device," and "vibrator," indicating the areas where the invention must differentiate itself[4].

International Patent Cooperation

The patent is part of a broader international patent landscape. Databases such as PATENTSCOPE and the Cooperative Patent Classification (CPC) system facilitate global patent searches and classifications, ensuring that the invention aligns with international standards and does not infringe on existing patents[1].

Litigation and Validity

Challenges to Patent Validity

Patents can face challenges through inter partes review (IPR) or district court litigation. For example, in the case of Vascular Solutions LLC v. Medtronic, Inc., the court addressed issues of claim construction and indefiniteness, highlighting the complexities involved in determining patent validity[2].

Presumption of Validity

U.S. patents are accompanied by a presumption of validity, which can be challenged through legal proceedings. The burden of proof lies with the party challenging the patent to show that the claims are invalid due to anticipation, obviousness, or other grounds[2].

Metrics for Measuring Patent Scope

Independent Claim Length and Count

Research has suggested using metrics such as independent claim length and count to measure patent scope. These metrics can provide insights into the breadth and clarity of the patent claims. For instance, longer independent claims may indicate a broader scope, while a higher count of independent claims could suggest a more complex invention[3].

Industry Impact and Innovation

Biotechnology and Medical Devices

The use of advanced biotechnology, such as CRISPR-Cas12a for AAV-based gene editing, as mentioned in related patents, underscores the innovative nature of the aerosol delivery device. Such technologies can significantly impact the medical field by providing more efficient and precise methods for drug delivery[5].

Licensing and Litigation

The scope and clarity of patent claims can influence licensing and litigation costs. Overly broad or unclear claims can lead to increased legal disputes and higher costs, potentially hindering innovation. Therefore, the clarity and specificity of the claims in US10744277B2 are crucial for its commercial viability[3].

Conclusion

The United States Patent 10,744,277 represents a significant advancement in aerosol delivery technology. Understanding its scope, claims, and the broader patent landscape is essential for both legal and commercial purposes.

Key Takeaways

  • Technical Scope: The patent covers an aerosol delivery device with an aerosol generator, membrane, and vibrator.
  • Claims Analysis: Independent and dependent claims define the invention's scope, with claim construction being a critical legal aspect.
  • Patent Landscape: The patent is part of a global landscape, subject to prior art searches and international classifications.
  • Litigation and Validity: The patent's validity can be challenged, and it is subject to a presumption of validity.
  • Industry Impact: The invention has significant implications for medical device innovation and biotechnology.

FAQs

Q: What is the main invention described in US10744277B2?

A: The main invention is an aerosol delivery device that includes an aerosol generator, a membrane, and a vibrator.

Q: How is claim construction determined in patent law?

A: Claim construction is determined through legal proceedings and is a question of law subject to de novo review on appeal.

Q: What databases can be used to search for prior art related to this patent?

A: Databases such as the USPTO's Patent Public Search, PATENTSCOPE, and the Cooperative Patent Classification (CPC) database can be used.

Q: How can the scope of a patent be measured?

A: Metrics such as independent claim length and count can be used to measure the scope and clarity of patent claims.

Q: What are the potential industry impacts of this patent?

A: The patent could significantly impact the medical field by providing more efficient and precise methods for drug delivery, particularly in conjunction with advanced biotechnologies.

Sources

  1. Clemson University Libraries. Research and Course Guides: Patent Searching, Advanced.
  2. United States Court of Appeals for the Federal Circuit. VASCULAR SOLUTIONS LLC v. MEDTRONIC, INC.
  3. Hoover Institution. Patent Claims and Patent Scope.
  4. Google Patents. US10744277B2 - Aerosol delivery device and method of operating the aerosol delivery device.
  5. Drug Patent Watch. When do biologic drug patents expire and when will biosimilars be available?

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,744,277

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sumitomo Pharma Am LONHALA MAGNAIR KIT glycopyrrolate SOLUTION;INHALATION 208437-001 Dec 5, 2017 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y A METHOD OF USING AN AEROSOL DELIVERY DEVICE TO AEROSOLIZE GLYCOPYRROLATE FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,744,277

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
13197391Dec 16, 2013
PCT Information
PCT FiledDecember 15, 2014PCT Application Number:PCT/EP2014/077753
PCT Publication Date:June 25, 2015PCT Publication Number: WO2015/091356

International Family Members for US Patent 10,744,277

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2014365042 ⤷  Subscribe
European Patent Office 2883564 ⤷  Subscribe
European Patent Office 3082918 ⤷  Subscribe
European Patent Office 3711797 ⤷  Subscribe
European Patent Office 4434588 ⤷  Subscribe
Spain 2809565 ⤷  Subscribe
Japan 2017502742 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.